Genmab strikes deal with German biotech company

Denmark’s Genmab has signed a new million-dollar deal in the immuno-oncology field with Germany’s Biontech – a company which recently signed a highly lucrative deal with Eli Lilly.
Photo: Genmab, PR
Photo: Genmab, PR
BY STEFAN SINGH KAILAY

The Danish-based biotech group Genmab has signed a commercial agreement concerning its DuoBody technology with Germany’s Biontech in the immuno-oncology field, Genmab writes in an announcement.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading